- Home
- CAPL vs DAWN Comparison
CAPL vs DAWN Comparison
Compare CAPL & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPL
- DAWN
- Stock Information
- Founded
- CAPL 1992
- DAWN 2018
- Country
- CAPL United States
- DAWN United States
- Employees
- CAPL N/A
- DAWN N/A
- Industry
- CAPL Oil Refining/Marketing
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- CAPL Energy
- DAWN Health Care
- Exchange
- CAPL Nasdaq
- DAWN Nasdaq
- Market Cap
- CAPL 796.2M
- DAWN 658.9M
- IPO Year
- CAPL 2012
- DAWN 2021
- Fundamental
- Price
- CAPL $20.74
- DAWN $7.02
- Analyst Decision
- CAPL
- DAWN Strong Buy
- Analyst Count
- CAPL 0
- DAWN 7
- Target Price
- CAPL N/A
- DAWN $31.57
- AVG Volume (30 Days)
- CAPL 26.5K
- DAWN 1.3M
- Earning Date
- CAPL 08-06-2025
- DAWN 07-29-2025
- Dividend Yield
- CAPL 10.14%
- DAWN N/A
- EPS Growth
- CAPL 30.34
- DAWN N/A
- EPS
- CAPL 0.80
- DAWN N/A
- Revenue
- CAPL $3,694,780,000.00
- DAWN $161,922,000.00
- Revenue This Year
- CAPL N/A
- DAWN $17.98
- Revenue Next Year
- CAPL N/A
- DAWN $49.50
- P/E Ratio
- CAPL $25.99
- DAWN N/A
- Revenue Growth
- CAPL N/A
- DAWN N/A
- 52 Week Low
- CAPL $18.43
- DAWN $6.08
- 52 Week High
- CAPL $25.73
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- CAPL 36.62
- DAWN 58.34
- Support Level
- CAPL $20.55
- DAWN $6.52
- Resistance Level
- CAPL $21.03
- DAWN $7.24
- Average True Range (ATR)
- CAPL 0.43
- DAWN 0.26
- MACD
- CAPL 0.02
- DAWN 0.07
- Stochastic Oscillator
- CAPL 16.90
- DAWN 78.37
About CAPL CrossAmerica Partners LP Common Units representing limited partner interests
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.